Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Rectal Neoplasms 5Colorectal Neoplasms 4Colonic Neoplasms 4Urinary Bladder Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Klatskin Tumor 2Gallbladder Neoplasms 2Cholangiocarcinoma 2Tongue Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Salivary Gland Neoplasms 1Pancreatic Intraductal Neoplasms 1PRETEXT I Hepatoblastoma 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Lymphoid Interstitial Pneumonia 1HIV Infections 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1DNA Repair-Deficiency Disorders 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Clinical Stage I Gastric Cancer AJCC v8 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 10Cisplatin 10Specimen Handling 8Radiotherapy 6Platinum 61,2-diaminocyclohexaneplatinum II citrate 6Paclitaxel 5Radiotherapy, Intensity-Modulated 4Fluorodeoxyglucose F18 4Biopsy 4Radiation 3Nivolumab 3Fluorouracil 3Carboplatin 3fludarabine phosphate 2fludarabine 2aldesleukin 2Taxes 2Radiosurgery 2Immunoglobulin G 2Gemcitabine 2Docetaxel 2Disulfides 2Cyclophosphamide 2Cetuximab 2(225)Ac-DOTA-c(RGDyK) 2veliparib 1peposertib 1pembrolizumab 1ipatasertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Oropharyngeal Neoplasms × dehydroftorafur × Clear all
NCT01711541 2023-06-07

Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer

National Cancer Institute (NCI)

Phase 1/2 Completed
24 enrolled 12 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡